Celldex Therapeutics
CLDX • NASDAQ
Celldex Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Anthony S. Marucci, with a market cap of $2.6B.
Market Cap$2.6B
Employees160.0
CEOAnthony S. Marucci
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Celldex Therapeutics FAQ
Common questions about Celldex Therapeutics
Celldex Therapeutics is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $1.0M.
Celldex Therapeutics has approximately 160 employees.